caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1770809907

Mona CabreraM.D.

Family PracticeSilver City, NMI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
PRESCRIBING · PART D · 2024
Total Rx claims
1,951
Beneficiaries
—
Total drug cost
$140K
Distinct drugs
56
Brand share
17.2%
Top prescribed drugs
Atorvastatin Calcium146 claims
Lisinopril125 claims
Levothyroxine Sodium111 claims
Hydrochlorothiazide96 claims
Metformin Hcl77 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Mona Cabrera's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
HIDALGO MEDICAL SERVICES56210
HIDALGO MEDICAL SERVICES50134
GILA REGIONAL MEDICAL CENTER49147
TRICORE REFERENCE LABORATORIES46231
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$110
Payment records
5
By payment type
Food and Beverage$110
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
58
Unique beneficiaries
—
Total services
130
Distinct HCPCS
2
Medicare payment
$7K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 617 Family Practice providers in NM — below median (cohort median 308).